Skip to content

Patient Activation in Dialysis

Patient Activation in Incident Dialysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04066140
Acronym
PAMD
Enrollment
227
Registered
2019-08-26
Start date
2019-06-17
Completion date
2020-06-17
Last updated
2020-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure, Chronic, Renal Dialysis

Keywords

patient activation, self management

Brief summary

Patient activation refers to patients' willingness and ability to make independent actions to manage their health and care and requires knowledge, skill and confidence. This study aims to explore activation levels of incident dialysis patients at start of dialysis and after 3 months of dialysis.

Detailed description

Patient activation refers to patients' willingness and ability to make independent actions to manage their health and care and requires knowledge, skill and confidence. This study aims to explore activation levels, using the 13 item PAM-13 survey, of incident dialysis patients at start of dialysis and after 3 months of dialysis.

Interventions

OTHERNo intervention

No Intervention. Observational Study.

Sponsors

Satellite Healthcare
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-Incident dialysis patients commencing at Satellite Healthcare during study recruitment dates

Exclusion criteria

* Age \< 18 years * Started dialysis more than 3 weeks prior to identification * Transitioning to dialysis at a participating center from a non-participating center, when that patient has been on dialysis for more than 3 weeks at any center. * Transitioning to dialysis after kidney transplant failure * Inability to participate because of cognitive impairment or active psychological condition

Design outcomes

Primary

MeasureTime frameDescription
Patient Activation3 monthsPatient Activation as measured by PAM-13 instrument

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026